StockTipsArenaBeta

BUY Thyrocare Technologies Limited — Rahul Sharma, JM Financial

BUYThyrocare Technologies Limited
Thyrocare Technologies share price target & all analyst calls

byRahul Sharma, JM FinancialHorizon: NA (inferred Swing (≤2wk))31 Aug 2026via NDTV Profit (Live)

Entry₹580.65Inferred
Target₹660
Total upside +13.67% (call closed)
Stop lossNot given
At expiry₹550.2511 Sept 2026, 3:30 pm
Expired-5.24%
Follow Rahul Sharma for new calls(25% target hit, 53 closed calls)Get alertsWatch THYROCARE for new buy/sell callsGet alertsSee 114 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 11 Sept 2026
1 supporting2 neutral0 opposing
Supports the BUY call (1)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·23 Jul · 2mo ago

Neutral / worth noting (2)

Thyrocare Technologies Ltd informs about the approval of the Scheme of Amalgamation of Docon Technologies Private Limited with API Holdings Limited by the NCLT. Upon effectiveness, Docon will be amalg

BSE · Company Update·1 Sept · 1w ago

(opens in new tab)

API Holdings repays ₹1,050 crore, frees Thyrocare shares from pledge

NewsHbl·17 Aug · 3w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Thyrocare Technologies

All analyst calls on Thyrocare Technologies

More from Rahul Sharma, JM Financial

Every call and its outcome